Introduction
Patient Group Directions (PGDs) provide a legal framework that allows some registered health professionals to supply and/or administer a specified medicine(s) to a pre-defined group of patients, without them having to see a doctor (or dentist) or non-medical prescriber.
PGDs are NOT intended as a substitute for individual prescribing where there is an opportunity in the care pathway for a medicine or medicines to be prescribed i.e. where an episode of care is planned.
PGDs must only include medicines with a UK marketing authorisation, in line with national legislation. Off-label use of a licensed medicine in a PGD is considered only when clearly justified by best clinical practice.
Only formulary drugs can be approved for inclusion on a PGD.
A PGD must only be written after careful consideration of all the available methods of administration and supply of medicines, including prescribing by medical or non-medical prescribers.
Policy Details
| Download: | N/A |
| Compiled by: | Olatokunbo Ogunbanjo, Chief Pharmacist |
| Ratified by: | Drug and Therapeutics Committee |
| Date Ratified: | October 2021 |
| Date Issued: | October 2021 |
| Review Date: | October 2024 |
| Target Audience: | Doctors, Nurses, Pharmacy, Allied Health Care Professionals |
| Contact name: | Olatokunbo Ogunbanjo, Chief Pharmacist |
See also:
